The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 27815118 |
112 |
Discovery of phenoxyindazoles and phenylthioindazoles as ROR¿ inverse agonists. |
Galderma R & D |
| 24831826 |
59 |
Small molecule inhibitors targeting activator protein 1 (AP-1). |
University Of Texas Medical Branch |
| 19239230 |
42 |
Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands. |
Acadia Pharmaceuticals |
| | 27 |
Synthesis and biological activities of new heterocyclic aromatic retinoids |
TBA |
| 20925433 |
21 |
Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives. |
Aristotle University Of Thessaloniki |
| 20638278 |
145 |
Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists. |
Phenex Pharmaceuticals |
| 19502054 |
3 |
Identification of a chromone-based retinoid containing a polyolefinic side chain via facile synthetic routes. |
Temple University |
| | 61 |
Synthesis and structure-activity relationships of potent conformationally restricted retinoid X receptor ligands |
TBA |
| | 99 |
Synthesis and structure-activity relationships of potent retinoid X receptor ligands |
TBA |
| | 56 |
Synthesis and biological activity of 1,2,3,4-tetrahydroquinoline and 3,4-(1H)-dihydroquinolin-2-one analogs of retinoic acid |
TBA |
| | 22 |
Synthesis and receptor binding affinity of conformationally restricted retinoic acid analogues |
TBA |
| | 83 |
Synthesis of highly potent RXR-specific retinoids: The use of a cyclopropyl group as a double bond isostere |
TBA |
| | 31 |
Synthesis and pharmacological activity of conformationally restricted, acetylenic retinoid analogs |
TBA |
| | 54 |
Differential RXR & RAR activity of stilbene retinoid analogs bearing thiazole and imidazole carboxylic acids |
TBA |
| | 3 |
N-linked analogs of retinoid O-glucuronides: potential cancer chemopreventive/chemotherapeutic agents |
TBA |
| | 35 |
Structural basis for the differential RXR & RAR activity of stilbene retinoid analogs |
TBA |
| 19058965 |
30 |
Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives. |
University Of Lille |
| 16190748 |
10 |
Ligand recognition by RAR and RXR receptors: binding and selectivity. |
Universidad De Santiago De Compostela |
| 15125928 |
44 |
Design and synthesis of benzofused heterocyclic RXR modulators. |
Eli Lilly |
| 14592510 |
150 |
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile. |
Ligand Pharmaceuticals |
| 12951091 |
36 |
Design and synthesis of fluorinated RXR modulators. |
Eli Lilly |
| 12801232 |
71 |
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes. |
Ligand Pharmaceuticals |
| 12482435 |
75 |
Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid. |
Ligand Pharmaceuticals |
| 12372520 |
37 |
Synthesis and biological activity of retinoic acid receptor-alpha specific amides. |
Allergan |
| 11428923 |
39 |
Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes. |
Allergan |
| 11412986 |
3 |
An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studies. |
The Ohio State University |
| 11354380 |
3 |
Syntheses and evaluation of quinoline derivatives as novel retinoic acid receptor alpha antagonists. |
Eisai |
| 11277515 |
51 |
Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity. |
Allergan |
| 10762039 |
3 |
Syntheses and evaluation of naphthalenyl- and chromenyl-pyrrolyl-benzoic acids as potent and selective retinoic acid receptor alpha agonists. |
Eisai |
| 10762038 |
3 |
Novel retinoic acid receptor alpha agonists: syntheses and evaluation of pyrazole derivatives. |
Eisai |
| 10669568 |
27 |
Syntheses and structure-activity relationships of 5,6,7, 8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor alpha agonistic activity. |
Eisai |
| 10585206 |
45 |
Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid. |
Università |
| 10543887 |
12 |
Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors. |
University Of Oklahoma Health Sciences Center |
| 10201840 |
33 |
A new class of potent RAR antagonists: dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids. |
Allergan |
| 10098670 |
24 |
Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands. |
Allergan |
| 10098666 |
48 |
High affinity retinoic acid receptor antagonists: analogs of AGN 193109. |
Allergan |
| 10052980 |
138 |
Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells. |
Ligand Pharmaceuticals |
| 9733501 |
33 |
Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships. |
University Of Oklahoma Health Sciences Center |
| 9435893 |
46 |
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. |
University Of Tokyo |
| 8978832 |
18 |
Identification of retinoic acid receptor beta subtype specific agonists. |
Allergan |
| 8784454 |
76 |
Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid. |
Allergan |
| 8765503 |
39 |
Identification of the first retinoid X, receptor homodimer antagonist. |
Ligand Pharmaceuticals |
| 8759622 |
15 |
Identification of a retinoic acid receptor alpha subtype specific agonist. |
Allergan |
| 8709094 |
41 |
Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells. |
Ligand Pharmaceuticals |
| 8691435 |
33 |
Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids. |
Pharmaceutical Research Institute |
| 8544175 |
75 |
Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. |
Cird Galderma |
| 8410972 |
52 |
Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity. |
Sri International |
| 8308867 |
72 |
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. |
Ligand Pharmaceuticals |
| 8071941 |
240 |
Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. |
Ligand Pharmaceuticals |
| 7636843 |
40 |
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids. |
Allergan |
| 7490725 |
9 |
Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. |
Allergan |
| 19361210 |
44 |
8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists. |
Bristol-Myers Squibb |
Search and Browse
